A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

The Mediterranean diet shows promise in managing both systemic and organ-specific autoimmune diseases, including rheumatoid ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the TRANSFORM trial of lisocabtagene maraleucel in B-cell ...

Amtagvi® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

A Georgetown University professor is continuing novel research on the impact of DNA patterns on breast cancer.  Yun-Ling ...

Iovance Biotherapeutics (NASDAQ: IOVA) is one such company right now, entering a decade of incredible growth. Here's why ...

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

Nickel is a common metal present in the environment, and human exposure can occur through diet, the environment and materials we touch. Soluble and insoluble nickel compounds can lead to several ...

During differentiation, immature cells express specific genes for different specialized function ... in immunotherapy by reprogramming types of white blood cells called T-lymphocytes to target cancer ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering ...